Comparison of Semaglutide or Dulaglutide Versus Empagliflozin for Risk for Death and Cardiovascular Outcomes Among Patients With Type 2 Diabetes : Two Target Trial Emulation Studies.
- Journal:
- Annals of Internal Medicine
- Published:
- Affiliations:
- 6
- Authors:
- 8
| Institutions | Authors | Share |
|---|---|---|
| University of Pittsburgh Medical Center (UPMC), United States of America (USA) | 0.69 | |
| University of Pittsburgh (Pitt), United States of America (USA) | 0.31 |